Literature DB >> 1974131

Nuclease treatment results in high specific purification of Creutzfeldt-Jakob disease infectivity with a density characteristic of nucleic acid-protein complexes.

T Sklaviadis1, A Akowitz, E E Manuelidis, L Manuelidis.   

Abstract

Representative preparations of partially purified Creutzfeldt-Jakob disease (CJD), including disaggregated density gradient fractions, were treated with a variety of nucleases. RNases as well as exhaustive digestions with micrococcal nuclease did not significantly diminish infectivity, but resulted in an approximately 7,000-fold specific purification of infectivity with respect to nucleic acid. Protected nucleic acids included species of up to 2,000 bases in length. After nuclease treatment, infectivity co-migrated with nucleic acid-protein complexes at a density of 1.27 g/cm3 in sucrose. Substantial specific protein purification were also achieved in the gradient step (approximately 11,000-fold), where 70% the host Gp34 ("prion protein") as well as other free proteins separated from infectivity. These CJD purifications are better than those previously attained in scrapie, and may be useful for further studies of non-host protein and nucleic acid species. The data are consistent with the hypothesis that CJD-like agents are composed of nucleic acid-protein complexes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974131     DOI: 10.1007/bf01323166

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  30 in total

1.  Characterization of major peptides in Creutzfeldt-Jakob disease and scrapie.

Authors:  T Sklaviadis; L Manuelidis; E E Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

2.  Potential retroviral RNAs in Creutzfeldt-Jakob disease.

Authors:  G H Murdoch; T Sklaviadis; E E Manuelidis; L Manuelidis
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

3.  A novel cDNA/PCR strategy for efficient cloning of small amounts of undefined RNA.

Authors:  A Akowitz; L Manuelidis
Journal:  Gene       Date:  1989-09-30       Impact factor: 3.688

Review 4.  Potential involvement of retroviral elements in human dementias.

Authors:  L Manuelidis; G Murdoch; E E Manuelidis
Journal:  Ciba Found Symp       Date:  1988

5.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.

Authors:  R J Kascsak; R Rubenstein; P A Merz; M Tonna-DeMasi; R Fersko; R I Carp; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

6.  Physical properties of the Creutzfeldt-Jakob disease agent.

Authors:  T K Sklaviadis; L Manuelidis; E E Manuelidis
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

Review 7.  Staphylococcal nuclease reviewed: a prototypic study in contemporary enzymology. I. Isolation; physical and enzymatic properties.

Authors:  P W Tucker; E E Hazen; F A Cotton
Journal:  Mol Cell Biochem       Date:  1978-12-22       Impact factor: 3.396

8.  Transmission of Creutzfeldt-Jakob disease with scrapie-like syndromes to mice.

Authors:  E E Manuelidis; E J Gorgacz; L Manuelidis
Journal:  Nature       Date:  1978-02-23       Impact factor: 49.962

9.  Towards purification of the scrapie agent.

Authors:  H Diringer; H Hilmert; D Simon; E Werner; B Ehlers
Journal:  Eur J Biochem       Date:  1983-08-15

10.  Purification of the scrapie agent by density gradient centrifugation.

Authors:  R F Marsh; C Dees; B E Castle; W F Wade; T L German
Journal:  J Gen Virol       Date:  1984-02       Impact factor: 3.891

View more
  9 in total

1.  Antibody to DNA detects scrapie but not normal prion protein.

Authors:  Wen-Quan Zou; Jian Zheng; Donald M Gray; Pierluigi Gambetti; Shu G Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-20       Impact factor: 11.205

Review 2.  Prions: Beyond a Single Protein.

Authors:  Alvin S Das; Wen-Quan Zou
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

3.  Nucleic acid binding proteins in highly purified Creutzfeldt-Jakob disease preparations.

Authors:  T Sklaviadis; A Akowitz; E E Manuelidis; L Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

4.  Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt-Jakob disease.

Authors:  A Akowitz; T Sklaviadis; L Manuelidis
Journal:  Nucleic Acids Res       Date:  1994-03-25       Impact factor: 16.971

5.  Microglial activation varies in different models of Creutzfeldt-Jakob disease.

Authors:  C A Baker; Z Y Lu; I Zaitsev; L Manuelidis
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

6.  Quantitative recovery of scrapie agent with minimal protein from highly infectious cultures.

Authors:  Ru Sun; Ying Liu; He Zhang; Laura Manuelidis
Journal:  Viral Immunol       Date:  2008-09       Impact factor: 2.257

7.  The association between PrP and infectivity in scrapie and BSE infected mouse brain.

Authors:  R A Somerville; A J Dunn
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Protected endogenous retroviral sequences copurify with infectivity in experimental Creutzfeldt-Jakob disease.

Authors:  A Akowitz; E E Manuelidis; L Manuelidis
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

Review 9.  Prions and related neurological diseases.

Authors:  M Pocchiari
Journal:  Mol Aspects Med       Date:  1994
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.